Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.

Katz N, Hale M, Morris D, Stauffer J.

Postgrad Med. 2010 Jul;122(4):112-28. doi: 10.3810/pgm.2010.07.2179.

PMID:
20675975
[PubMed - indexed for MEDLINE]
2.

A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis.

Munera C, Drehobl M, Sessler NE, Landau C.

J Opioid Manag. 2010 May-Jun;6(3):193-202.

PMID:
20642248
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.

Afilalo M, Etropolski MS, Kuperwasser B, Kelly K, Okamoto A, Van Hove I, Steup A, Lange B, Rauschkolb C, Haeussler J.

Clin Drug Investig. 2010;30(8):489-505. doi: 10.2165/11533440-000000000-00000.

PMID:
20586515
[PubMed - indexed for MEDLINE]
4.

Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain.

Hale M, Khan A, Kutch M, Li S.

Curr Med Res Opin. 2010 Jun;26(6):1505-18. doi: 10.1185/03007995.2010.484723. Erratum in: Curr Med Res Opin. 2010 Aug;26(8):1904.

PMID:
20429852
[PubMed - indexed for MEDLINE]
5.

ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety.

Katz N, Sun S, Johnson F, Stauffer J.

J Pain. 2010 Apr;11(4):303-11. doi: 10.1016/j.jpain.2009.07.017. Epub 2009 Nov 27.

PMID:
19944650
[PubMed - indexed for MEDLINE]
6.

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, G√łtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D.

Ann Intern Med. 2009 Aug 18;151(4):W65-94. Epub 2009 Jul 20.

PMID:
19622512
[PubMed - indexed for MEDLINE]
7.

AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program.

Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, Chang S, Helfand M.

J Clin Epidemiol. 2010 May;63(5):513-23. doi: 10.1016/j.jclinepi.2009.03.009.

PMID:
19595577
[PubMed - indexed for MEDLINE]
8.

The pain quality response profile of oxymorphone extended release in the treatment of low back pain.

Gould EM, Jensen MP, Victor TW, Gammaitoni AR, White RE, Galer BS.

Clin J Pain. 2009 Feb;25(2):116-22. doi: 10.1097/AJP.0b013e3181817ac8.

PMID:
19333156
[PubMed - indexed for MEDLINE]
9.
10.

Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.

Hanna M, O'Brien C, Wilson MC.

Eur J Pain. 2008 Aug;12(6):804-13. doi: 10.1016/j.ejpain.2007.12.010. Epub 2008 Feb 8.

PMID:
18262450
[PubMed - indexed for MEDLINE]
11.

A community-based evaluation of sudden death associated with therapeutic levels of methadone.

Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K.

Am J Med. 2008 Jan;121(1):66-71. doi: 10.1016/j.amjmed.2007.10.009.

PMID:
18187075
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Rates of adverse events of long-acting opioids in a state Medicaid program.

Hartung DM, Middleton L, Haxby DG, Koder M, Ketchum KL, Chou R.

Ann Pharmacother. 2007 Jun;41(6):921-8. Epub 2007 May 15. Erratum in: Ann Pharmacother. 2007 Sep;41(9):1552.

PMID:
17504834
[PubMed - indexed for MEDLINE]
14.

Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.

Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, Colucci SV, Richards P.

Clin J Pain. 2007 May;23(4):287-99.

PMID:
17449988
[PubMed - indexed for MEDLINE]
16.

A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.

Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.

J Opioid Manag. 2006 Nov-Dec;2(6):325-8, 331-3.

PMID:
17326594
[PubMed - indexed for MEDLINE]
17.

The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.

Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.

J Opioid Manag. 2006 May-Jun;2(3):155-66. Erratum in: J Opioid Manag. 2006 Sep-Oct;2(5):276.

PMID:
17319449
[PubMed - indexed for MEDLINE]
18.

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.

Katz N, Rauck R, Ahdieh H, Ma T, Gerritsen van der Hoop R, Kerwin R, Podolsky G.

Curr Med Res Opin. 2007 Jan;23(1):117-28.

PMID:
17257473
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.

Hale ME, Ahdieh H, Ma T, Rauck R; Oxymorphone ER Study Group 1.

J Pain. 2007 Feb;8(2):175-84. Epub 2006 Dec 4.

PMID:
17145204
[PubMed - indexed for MEDLINE]
20.

Opioid analgesic involvement in drug abuse deaths in American metropolitan areas.

Paulozzi LJ.

Am J Public Health. 2006 Oct;96(10):1755-7.

PMID:
17008568
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk